Alizadeh Sadegh, Grindheim Sophie, Klöckner Christian A, Følling Ingrid S
Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Science, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Front Public Health. 2025 Jul 28;13:1649655. doi: 10.3389/fpubh.2025.1649655. eCollection 2025.
In Norway, one treatment option for patients with obesity has been a multi-component lifestyle program with a continuous stay at rehabilitation centers. During the COVID-19 pandemic, these stays were reduced, and digital follow-up for patients from home was introduced. How these changes affected patients' health outcomes after treatment is unknown. This study aimed to investigate health outcomes for patients who attended lifestyle treatment and to compare patients who attended treatment before COVID-19 with patients who attended during COVID-19.
A retrospective pre-post design was used. A total of 103 patients (mean age 45.4 years, 64% women) with a mean Body Mass Index (BMI) of 42.3 kg/m were included of whom 53 attended treatment before COVID-19 and 50 attended treatment during COVID-19. Health outcomes measured were BMI, Physical Activity (PA) levels, and Health-Related Quality of Life (HRQoL). Data were collected at baseline and after 9 weeks of treatment for both groups.
All patients had a significant reduction in BMI after treatments, with no differences between the groups. PA levels and HRQoL increased for both groups, however, the group that attended treatment before COVID-19 had significantly higher PA levels and HRQoL ( < 0.001) than the group that attended during COVID-19.
This study demonstrates that structured lifestyle treatment supports improvements in BMI, HRQoL, and PA levels, even with reduced in-person contact. Although differences were observed between treatment periods, further research is needed to understand how the delivery mode and specific components of digital and in-person treatments affect health outcomes, providing insights to optimize future lifestyle interventions for individuals with obesity.
在挪威，肥胖患者的一种治疗选择是参加多成分生活方式项目，并在康复中心持续停留。在新冠疫情期间，这些停留时间减少，并引入了患者居家的数字随访。这些变化如何影响治疗后患者的健康结果尚不清楚。本研究旨在调查参加生活方式治疗的患者的健康结果，并比较新冠疫情前参加治疗的患者与疫情期间参加治疗的患者。
采用回顾性前后对照设计。共纳入103例患者（平均年龄45.4岁，64%为女性），平均体重指数（BMI）为42.3kg/m²，其中53例在新冠疫情前参加治疗，50例在疫情期间参加治疗。测量的健康结果包括BMI、身体活动（PA）水平和健康相关生活质量（HRQoL）。两组均在基线和治疗9周后收集数据。
所有患者治疗后BMI均显著降低，两组间无差异。两组的PA水平和HRQoL均有所提高，然而，新冠疫情前参加治疗的组的PA水平和HRQoL显著高于（<0.001）疫情期间参加治疗的组。
本研究表明，结构化的生活方式治疗有助于改善BMI、HRQoL和PA水平，即使面对面接触减少。尽管在治疗期间观察到了差异，但仍需要进一步研究以了解数字治疗和面对面治疗的提供模式及具体组成部分如何影响健康结果，从而为优化未来肥胖个体的生活方式干预提供见解。
